BioSpace News Archive

Drug Development

Kineta Unveils New Preclinical Data on its Anti-CD27 Agonist Lead Antibodies at AACR 2022

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today the presentation of preclinical data on the company’s anti-CD27 agonist lead antibodies at the American Association for Cancer Research (AACR) Annual Meeting 2022.

April 13, 2022
·
3 min read
Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims

APTI has been informed that the first set of claims from US patent application 16/180,960 have been allowed.

April 13, 2022
·
4 min read
Job Trends

AbbVie Celebrates 30th Anniversary of CF Scholarship with Opening of Application Period for Students with Cystic Fibrosis

AbbVie today announced that the AbbVie Cystic Fibrosis (CF) Scholarship program is now accepting applications for the 2022-2023 academic school year.

April 13, 2022
·
4 min read
Business

Georgia Bio Names South Forsyth High School Junior as 2022 Georgia BioGENEius Winner

Georgia Bio and the BioEd Institute named Mokshith Mannuru, a junior at South Forsyth High School in Cumming, GA, as the winner of the 2022 Georgia BioGENEius Challenge.

April 13, 2022
·
4 min read
Drug Development

Urovant Sciences to Present Interim Data from Phase 2a Study of Potential Novel Gene Therapy, URO-902, and New Analyses of Data from Phase 3 EMPOWUR Extension Trial of GEMTESA® (vibegron) 75 mg at 2022 AUA Annual Meeting

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., announced that data from a Phase 2a trial of the investigational, novel gene therapy, URO-902, will feature as a late-breaker at the 2022 annual meeting of the American Urological Association, May 13-16, in New Orleans, Louisiana.

April 13, 2022
·
10 min read
Policy

Biosimilar Solutions Initiates Registrational Clinical Trial for Biosimilar Version Neulasta

OcyonBio, LLC’s client Biosimilar Solutions, Inc., announces it has started its registrational clinical trials for the biosimilar version of Neulasta Filgrastim, a granulocyte-colony stimulating factor.

April 13, 2022
·
3 min read
Premier Medical Laboratory Services Receives College of American Pathologists (CAP) Accreditation

With this certification, PMLS is regarded as one of the world’s top-ranked labs for medical diagnostics which exceeds the industry’s clinical laboratory standards.

April 13, 2022
·
3 min read
Cell Separation Market Explore Growth Factors, Competitive Analysis of Key Industry Players (2022-2030)

At the start, the report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth.

April 13, 2022
·
4 min read
Business

Merit Medical Systems to Announce First Quarter Results on April 27, 2022

Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it will release its financial results for the quarter ended March 31, 2022, after the close of the stock market on Wednesday, April 27, 2022.

April 13, 2022
·
1 min read
Allergy Diagnostic Market Dynamics that Challenge New Entrants to the Sector

Allergy is an exaggerated reaction of invulnerable frameworks, which causes skin disturbance, roughage fever, asthma, hypersensitivity and different side effects.

April 13, 2022
·
3 min read